This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Hepanova, Inc.. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Belle Xiaohong Wang: Innovator in Nonalcoholic Fatty Liver Disease Treatment
Introduction
Belle Xiaohong Wang is a prominent inventor based in Germantown, MD (US). She has made significant contributions to the field of medicine, particularly in the treatment of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). With a total of 2 patents, her work is paving the way for innovative therapeutic methods.
Latest Patents
Wang's latest patents focus on amino-aryl-benzamide compounds and their methods of use. One of her notable inventions is a method for the treatment and/or reduction of NAFLD and NASH. This method utilizes active amino-aryl-benzamide compounds and outlines the preparation methods for these compounds. Her research is crucial in addressing these prevalent liver conditions.
Career Highlights
Belle Xiaohong Wang is currently associated with Hepanova, Inc., where she continues to advance her research and development efforts. Her work is characterized by a commitment to improving health outcomes for patients suffering from liver diseases.
Collaborations
Wang collaborates with esteemed colleagues, including Yongmei Li and Qiong Li. These partnerships enhance her research capabilities and contribute to the innovative solutions being developed at Hepanova, Inc.
Conclusion
Belle Xiaohong Wang is a dedicated inventor whose work in the treatment of liver diseases is making a significant impact. Her innovative approaches and collaborations are essential in the ongoing fight against NAFLD and NASH.